| __timestamp | Alpine Immune Sciences, Inc. | Biogen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 1893422000 |
| Thursday, January 1, 2015 | 16054000 | 2012800000 |
| Friday, January 1, 2016 | 23316000 | 1973300000 |
| Sunday, January 1, 2017 | 10626000 | 2253600000 |
| Monday, January 1, 2018 | 28970000 | 2597200000 |
| Tuesday, January 1, 2019 | 35847000 | 2280600000 |
| Wednesday, January 1, 2020 | 27185000 | 3990900000 |
| Friday, January 1, 2021 | 58742000 | 2501200000 |
| Saturday, January 1, 2022 | 70243000 | 2231100000 |
| Sunday, January 1, 2023 | 80904000 | 2702600000 |
| Monday, January 1, 2024 | 2041800000 |
Unleashing insights
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, Biogen Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting approaches to R&D investment. Biogen, a giant in the industry, consistently allocated substantial resources, with R&D expenses peaking at nearly $4 billion in 2020. This represents a staggering 110% increase from 2014, underscoring their commitment to pioneering treatments.
Conversely, Alpine Immune Sciences, a smaller player, has shown a remarkable growth trajectory in its R&D spending. From 2014 to 2023, their investment surged by over 560%, reaching approximately $81 million. This rapid increase highlights their aggressive pursuit of innovation despite limited resources.
These trends reflect broader industry dynamics, where established firms leverage vast resources, while emerging companies drive innovation through focused investments.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.